A detailed history of Macquarie Group LTD transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 8,995 shares of SERA stock, worth $38,858. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,995
Holding current value
$38,858
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$6.03 - $8.83 $54,239 - $79,425
8,995 New
8,995 $77,000
Q1 2024

May 14, 2024

BUY
$5.05 - $10.0 $4,454 - $8,820
882 New
882 $8,000

Others Institutions Holding SERA

About SERA PROGNOSTICS, INC.


  • Ticker SERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 29,596,900
  • Market Cap $128M
  • Description
  • Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...
More about SERA
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.